HBE Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
HBE Wealth Management's LLY Position: Q3 2026 in Review
HBE Wealth Management increased its Eli Lilly (LLY) stake by 0.34% in Q3 2026, buying an estimated $1.18K and bringing the position to 291 shares worth $337K. The position accounts for 0.24% of the portfolio, ranked #40.
HBE Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $348K in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- HBE Wealth Management held 291 shares of Eli Lilly worth $337K as of Q3 2026.
- HBE Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
- Eli Lilly made up 0.24% of HBE Wealth Management's portfolio in Q3 2026, its #40 holding.
- HBE Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- HBE Wealth Management's Eli Lilly position peaked at $348K in Q2 2026.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on HBE Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.